| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-04-27 22:19:46 UTC |
|---|
| Updated at | 2022-04-27 22:19:46 UTC |
|---|
| NP-MRD ID | NP0050873 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Gelsemicine |
|---|
| Description | Geissospermine belongs to the class of organic compounds known as strychnos alkaloids. These are alkaloids having a core structure based on the strychnan, stemmadenine (seco-curan), or the akuammicine (curan) skeleton. Gelsemicine is found in Apis cerana, Geissospermum laeve, Gelsemium elegans, Gelsemium sempervirens and Mostuea brunonis. Gelsemicine was first documented in 2009 (PMID: 19463267). Based on a literature review a small amount of articles have been published on geissospermine (PMID: 22143154) (PMID: 32920358) (PMID: 28282127) (PMID: 20844909). |
|---|
| Structure | CC[C@@H]1CN2CC[C@@]34[C@@H]2C[C@@H]1[C@@H]1CO[C@@H]([C@@H]([C@H]2C[C@@H]5N(CCC6=C5NC5=CC=CC=C65)C\C2=C\C)C(=O)OC)N([C@H]31)C1=C4C=CC=C1 InChI=1S/C40H48N4O3/c1-4-23-21-43-17-15-40-30-11-7-9-13-32(30)44-37(40)29(27(23)19-34(40)43)22-47-38(44)35(39(45)46-3)28-18-33-36-26(14-16-42(33)20-24(28)5-2)25-10-6-8-12-31(25)41-36/h5-13,23,27-29,33-35,37-38,41H,4,14-22H2,1-3H3/b24-5-/t23-,27+,28+,29+,33+,34+,35-,37+,38+,40-/m1/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C40H48N4O3 |
|---|
| Average Mass | 632.8490 Da |
|---|
| Monoisotopic Mass | 632.37264 Da |
|---|
| IUPAC Name | methyl (2R)-2-[(2R,3E,12bS)-3-ethylidene-1H,2H,3H,4H,6H,7H,12H,12bH-indolo[2,3-a]quinolizin-2-yl]-2-[(1R,9S,12S,13S,14S,19S,21S)-14-ethyl-10-oxa-8,16-diazahexacyclo[11.5.2.1^{1,8}.0^{2,7}.0^{16,19}.0^{12,21}]henicosa-2(7),3,5-trien-9-yl]acetate |
|---|
| Traditional Name | (R)-(methyl [(2R,3E,12bS)-3-ethylidene-1H,2H,4H,6H,7H,12H,12bH-indolo[2,3-a]quinolizin-2-yl][(1R,9S,12S,13S,14S,19S,21S)-14-ethyl-10-oxa-8,16-diazahexacyclo[11.5.2.1^{1,8}.0^{2,7}.0^{16,19}.0^{12,21}]henicosa-2(7),3,5-trien-9-yl]acetate) |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC[C@@H]1CN2CC[C@@]34[C@@H]2C[C@@H]1[C@@H]1CO[C@@H]([C@@H]([C@H]2C[C@@H]5N(CCC6=C5NC5=CC=CC=C65)C\C2=C\C)C(=O)OC)N([C@H]31)C1=C4C=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C40H48N4O3/c1-4-23-21-43-17-15-40-30-11-7-9-13-32(30)44-37(40)29(27(23)19-34(40)43)22-47-38(44)35(39(45)46-3)28-18-33-36-26(14-16-42(33)20-24(28)5-2)25-10-6-8-12-31(25)41-36/h5-13,23,27-29,33-35,37-38,41H,4,14-22H2,1-3H3/b24-5-/t23-,27+,28+,29+,33+,34+,35-,37+,38+,40-/m1/s1 |
|---|
| InChI Key | ISDWYSGTYITCHG-OCNKQYNFSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as strychnos alkaloids. These are alkaloids having a core structure based on the strychnan, stemmadenine (seco-curan), or the akuammicine (curan) skeleton. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Alkaloids and derivatives |
|---|
| Class | Strychnos alkaloids |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Strychnos alkaloids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Strychnan skeleton
- Corynanthean skeleton
- Akuammicine-skeleton
- Stemmadenine-skeleton
- Beta-carboline
- Carbazole
- Pyridoindole
- Quinolizine
- 3-alkylindole
- Indole
- Indole or derivatives
- Indolizidine
- Dialkylarylamine
- Aralkylamine
- N-alkylpyrrolidine
- Benzenoid
- 1,3-oxazinane
- Piperidine
- Oxazinane
- Methyl ester
- Heteroaromatic compound
- Pyrrolidine
- Pyrrole
- Tertiary aliphatic amine
- Tertiary amine
- Carboxylic acid ester
- Amino acid or derivatives
- Azacycle
- Organoheterocyclic compound
- Oxacycle
- Carboxylic acid derivative
- Monocarboxylic acid or derivatives
- Organopnictogen compound
- Hydrocarbon derivative
- Carbonyl group
- Organic oxygen compound
- Organic oxide
- Amine
- Organooxygen compound
- Organic nitrogen compound
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Mbeunkui F, Grace MH, Lategan C, Smith PJ, Raskin I, Lila MA: In vitro antiplasmodial activity of indole alkaloids from the stem bark of Geissospermum vellosii. J Ethnopharmacol. 2012 Jan 31;139(2):471-7. doi: 10.1016/j.jep.2011.11.036. Epub 2011 Nov 30. [PubMed:22143154 ]
- Lima JA, R Costa TW, da Fonseca ACC, do Amaral RF, Nascimento MDDSB, Santos-Filho OA, de Miranda ALP, Ferreira Neto DC, Lima FRS, Hamerski L, Tinoco LW: Geissoschizoline, a promising alkaloid for Alzheimer's disease: Inhibition of human cholinesterases, anti-inflammatory effects and molecular docking. Bioorg Chem. 2020 Nov;104:104215. doi: 10.1016/j.bioorg.2020.104215. Epub 2020 Aug 28. [PubMed:32920358 ]
- Fox Ramos AE, Alcover C, Evanno L, Maciuk A, Litaudon M, Duplais C, Bernadat G, Gallard JF, Jullian JC, Mouray E, Grellier P, Loiseau PM, Pomel S, Poupon E, Champy P, Beniddir MA: Revisiting Previously Investigated Plants: A Molecular Networking-Based Study of Geissospermum laeve. J Nat Prod. 2017 Apr 28;80(4):1007-1014. doi: 10.1021/acs.jnatprod.6b01013. Epub 2017 Mar 10. [PubMed:28282127 ]
- Araujo JQ, Lima JA, Pinto Ada C, de Alencastro RB, Albuquerque MG: Docking of the alkaloid geissospermine into acetylcholinesterase: a natural scaffold targeting the treatment of Alzheimer's disease. J Mol Model. 2011 Jun;17(6):1401-12. doi: 10.1007/s00894-010-0841-2. Epub 2010 Sep 16. [PubMed:20844909 ]
- Lima JA, Costa RS, Epifanio RA, Castro NG, Rocha MS, Pinto AC: Geissospermum vellosii stembark: anticholinesterase activity and improvement of scopolamine-induced memory deficits. Pharmacol Biochem Behav. 2009 May;92(3):508-13. doi: 10.1016/j.pbb.2009.01.024. Epub 2009 Feb 5. [PubMed:19463267 ]
|
|---|